Items Tagged ‘kyprolis’

February 8, 2018

Kyprolis Improves Survival in Recurrent Multiple Myeloma


CancerConnect News: The addition of Kyprolis® (carfilzomib) to the standard treatment regimen, Revlimid® (lenalidomide) and dexamethasone, improves survival for patients with multiple myeloma whose disease progressed or recurred following prior therapies. These results were recently presented at the 2017 annual meeting of the American Society of Hematology (ASH). About Multiple Myeloma In the United States […]

View full entry

Tags: kyprolis, Multiple Myeloma, News, revlimid